Thomas J. Schall
2016
In 2016, Thomas J. Schall earned a total compensation of $1.9M as President and Chief Executive Officer at ChemoCentryx, a 37% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $285,725 |
|---|---|
| Option Awards | $635,940 |
| Salary | $571,450 |
| Stock Awards | $357,000 |
| Other | $1,462 |
| Total | $1,851,627 |
Schall received $635.9K in option awards, accounting for 34% of the total pay in 2016.
Schall also received $285.7K in non-equity incentive plan, $571.5K in salary, $357K in stock awards and $1.5K in other compensation.
Rankings
In 2016, Thomas J. Schall's compensation ranked 5,243rd out of 14,075 executives tracked by ExecPay. In other words, Schall earned more than 62.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,243 out of 14,075 | 63rd |
Division Manufacturing | 1,887 out of 5,489 | 66th |
Major group Chemicals And Allied Products | 599 out of 1,895 | 68th |
Industry group Drugs | 447 out of 1,538 | 71st |
Industry Pharmaceutical Preparations | 355 out of 1,176 | 70th |
Source: SEC filing on April 10, 2017.
Schall's colleagues
We found two more compensation records of executives who worked with Thomas J. Schall at ChemoCentryx in 2016.